News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
699,220 Results
Type
Article (39728)
Company Profile (247)
Press Release (659245)
Multimedia
Podcasts (49)
Webinars (12)
Section
Business (204204)
Career Advice (2007)
Deals (35420)
Drug Delivery (95)
Drug Development (81066)
Employer Resources (172)
FDA (16184)
Job Trends (14859)
News (345248)
Policy (32543)
Tag
Academia (2554)
Accelerated approval (5)
Adcomms (20)
Allergies (85)
Alliances (49448)
ALS (89)
Alzheimer's disease (1379)
Antibody-drug conjugate (ADC) (126)
Approvals (16186)
Artificial intelligence (256)
Autoimmune disease (22)
Automation (16)
Bankruptcy (360)
Best Places to Work (11636)
BIOSECURE Act (19)
Biosimilars (105)
Biotechnology (175)
Bladder cancer (78)
Brain cancer (27)
Breast cancer (281)
Cancer (2276)
Cardiovascular disease (175)
Career advice (1676)
Career pathing (30)
CAR-T (152)
Cell therapy (427)
Cervical cancer (19)
Clinical research (66026)
Collaboration (838)
Company closure (1)
Compensation (548)
Complete response letters (19)
COVID-19 (2590)
CRISPR (40)
C-suite (245)
Cystic fibrosis (100)
Data (2228)
Decentralized trials (2)
Denatured (18)
Depression (43)
Diabetes (272)
Diagnostics (6372)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (120)
Drug pricing (100)
Drug shortages (25)
Duchenne muscular dystrophy (94)
Earnings (86705)
Editorial (37)
Employer branding (21)
Employer resources (146)
Events (112515)
Executive appointments (731)
FDA (17468)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (754)
Gene editing (106)
Generative AI (19)
Gene therapy (306)
GLP-1 (711)
Government (4419)
Grass and pollen (4)
Guidances (81)
Healthcare (18816)
Huntington's disease (24)
IgA nephropathy (27)
Immunology and inflammation (118)
Indications (29)
Infectious disease (2732)
Inflammatory bowel disease (141)
Inflation Reduction Act (8)
Influenza (51)
Intellectual property (96)
Interviews (311)
IPO (16511)
IRA (40)
Job creations (3630)
Job search strategy (1422)
Kidney cancer (10)
Labor market (38)
Layoffs (470)
Leadership (17)
Legal (7910)
Liver cancer (76)
Lung cancer (321)
Lymphoma (154)
Machine learning (7)
Management (58)
Manufacturing (309)
MASH (68)
Medical device (13379)
Medtech (13384)
Mergers & acquisitions (19461)
Metabolic disorders (691)
Multiple sclerosis (80)
NASH (16)
Neurodegenerative disease (90)
Neuropsychiatric disorders (27)
Neuroscience (1916)
NextGen: Class of 2025 (6512)
Non-profit (4480)
Now hiring (39)
Obesity (367)
Opinion (204)
Ovarian cancer (76)
Pain (88)
Pancreatic cancer (86)
Parkinson's disease (148)
Partnered (21)
Patents (238)
Patient recruitment (112)
Peanut (46)
People (57332)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20570)
Phase II (29083)
Phase III (21656)
Pipeline (1227)
Policy (141)
Postmarket research (2563)
Preclinical (8747)
Press Release (64)
Prostate cancer (107)
Psychedelics (30)
Radiopharmaceuticals (246)
Rare diseases (378)
Real estate (5907)
Recruiting (65)
Regulatory (22297)
Reports (46)
Research institute (2320)
Resumes & cover letters (349)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (69)
Series A (130)
Series B (86)
Service/supplier (11)
Sickle cell disease (52)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (29)
Startups (3578)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (43)
The Weekly (29)
Vaccines (691)
Venture capitalists (41)
Weight loss (235)
Women's health (35)
Worklife (16)
Date
Today (99)
Last 7 days (773)
Last 30 days (2716)
Last 365 days (32652)
2025 (10990)
2024 (35227)
2023 (40087)
2022 (51173)
2021 (55712)
2020 (54085)
2019 (46554)
2018 (35025)
2017 (32113)
2016 (31497)
2015 (37564)
2014 (31326)
2013 (26345)
2012 (28570)
2011 (29265)
2010 (27331)
Location
Africa (718)
Alabama (53)
Alaska (7)
Arizona (232)
Arkansas (13)
Asia (37854)
Australia (6186)
California (6190)
Canada (2032)
China (526)
Colorado (266)
Connecticut (275)
Delaware (150)
Europe (81411)
Florida (916)
Georgia (207)
Idaho (57)
Illinois (540)
India (25)
Indiana (312)
Iowa (11)
Japan (165)
Kansas (104)
Kentucky (24)
Louisiana (10)
Maine (62)
Maryland (898)
Massachusetts (4609)
Michigan (220)
Minnesota (394)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (64)
New Hampshire (63)
New Jersey (1742)
New Mexico (28)
New York (1762)
North Carolina (975)
North Dakota (8)
Northern California (2709)
Ohio (204)
Oklahoma (14)
Oregon (34)
Pennsylvania (1387)
Puerto Rico (12)
Rhode Island (33)
South America (1096)
South Carolina (23)
South Dakota (1)
Southern California (2328)
Tennessee (102)
Texas (921)
United States (23314)
Utah (183)
Virginia (147)
Washington D.C. (63)
Washington State (553)
West Virginia (3)
Wisconsin (55)
699,220 Results for "medigene inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Medigene Receives Milestone Payment from Regeneron Pharmaceuticals, Inc.
December 3, 2024
·
2 min read
Press Releases
Medigene Files Patent for Unique NK-Specific TCR Construct with European Patent Office
March 13, 2025
·
3 min read
Press Releases
Medigene AG announces closing of its first SEPA tranche
February 4, 2025
·
2 min read
Press Releases
Medigene and EpimAb Biotherapeutics Enter into a Co-Development Partnership for TCR-Guided T Cell Engagers
February 27, 2025
·
5 min read
Press Releases
Medigene AG Expands Patent Portfolio with Patent Grant for its JOVI Technology in the U.S.
February 19, 2025
·
2 min read
Medigene Reports Results of Annual General Meeting - June 24, 2024
Medigene AG, an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, announces the results of the Annul General Meeting.
June 24, 2024
·
3 min read
Press Releases
Medigene to Host Virtual R&D Event on Medigene’s Optimal 3S TCRs for TCR-Guided Precision Immunotherapies
September 16, 2024
·
3 min read
Press Releases
Medigene AG Announces Refocus of Corporate Strategy and Organizational Realignment
November 27, 2024
·
5 min read
Medigene to Present at the Cell and Gene Therapy In-Depth Focus Summit 2024
Medigene AG will present virtually at the 7th Cell and Gene Therapy In-Depth Focus Summit taking place from June 27-28, 2024, in Beijing, China.
June 21, 2024
·
2 min read
Medigene to Present at Upcoming May 2024 Conferences
Medigene AG will present a poster at the 21th Association for Cancer Immunotherapy Annual Meeting taking place May 15-17, 2024, in Mainz, as well as at the Healthcare House Call Virtual Conference hosted by The Benchmark Company on May 21 and 22, 2024.
May 7, 2024
·
3 min read
1 of 69,922
Next
